NCT01988324
- Conditions
- Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
- Locations
-
- VU Medical Center Amsterdam, Netherlands
- University Medical Center Groningen Groningen, Netherlands
Clinical trial condition
Metastatic Breast Cancer
Explore clinical trials studying Metastatic Breast Cancer. Study availability and eligibility vary by location and protocol.
640 public trials
137 recruiting studies
Metastatic Breast Cancer trial results
NCT02448420
- Conditions
- Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
- Locations
-
- ICO-Badalona Badalona, Barcelona, Spain
- Hospital General De Catalunya Sant Cugat del Vallès, Barcelona, Spain
- Hospital Universitario Rey Juan Carlos Móstoles, Madrid, Spain
- Complejo Hospitalario Universitario A Coruña A Coruña, Spain
NCT01942135
- Conditions
- Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
- Locations
-
- University of Alabama at Birmingham, The Kirklin Clinic Birmingham, Alabama, United States
- UAB Hospital-Investigational Drug Service Birmingham, Alabama, United States
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Southern Cancer Center, PC Daphne, Alabama, United States
NCT03703466
- Conditions
- Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
- Locations
-
- Mater Private Hospital North Sydney, New South Wales, Australia
- St Vincent's Hospital Sydney, New South Wales, Australia
- Ashford Cancer Centre Research Kurralta Park, South Australia, Australia
- Peter MacCallum Cancer Centre Melbourne, Victoria, Australia
NCT04134884
- Conditions
- Breast Diseases, Breast Neoplasms, Hormone Receptor Positive Tumor, +7 more
- Locations
-
- Indiana University Melvin & Bren Simon Cancer Center Indianapolis, Indiana, United States
- Wake Forest Baptist Comprehensive Cancer Center Winston-Salem, North Carolina, United States
NCT04834778
- Conditions
- Adenocarcinoma, Breast Diseases, Breast Neoplasms, +36 more
- Locations
-
- Karmanos Cancer Institute Detroit, Michigan, United States
- HealthPartners Cancer Care Center Saint Paul, Minnesota, United States
- Baylor University Medical Center Dallas, Texas, United States
- The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States
Completed
Palbociclib in Molecularly Characterized ER-positive/HER2-negative Metastatic Breast Cancer
NCT02536742
- Conditions
- Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +8 more
- Locations
-
- Sint-Augustinus Antwerp, Belgium
- Institut Jules Bodet Brussels, Belgium
- Cliniques Universitaires Saint-Luc Brussels, Belgium
- Antwerp University Hospital Edegem, Belgium
NCT05141708
- Conditions
- Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
- Locations
-
- Pfizer Inc. New York, United States
NCT03892096
- Conditions
- Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +23 more
- Locations
-
- CARTI Cancer Center Little Rock, Arkansas, United States
- Sutter Health - Palo Alto Medical Foundation Sunnyvale, California, United States
- Rocky Mountain Cancer Centers Denver, Colorado, United States
- IACT Health Columbus, Georgia, United States
Completed
Safety and Pharmacokinetics of ODM-209
NCT03878823
- Conditions
- Advanced Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
- Locations
-
- Rigshospitalet, University Hospital of Copenhagen Copenhagen, Denmark
- Helsinki University Central Hospital Helsinki, Finland
- Tampere University Hospital Tampere, Finland
- Institut Gustave Roussy Villejuif, France